Update on Suven Life Science. Exit stock. Quarterly results below par. We would recommend you to switch to Alembic Pharma: Share price 620. Target 750. 3 months. SL 550. Add on dips towards 580-590.
Reference call:
Re-enter Suven on dips towards 245. Target 310. SL 225. 3 months.
source https://gale.in/update-on-suven-life-science-exit-stock-quarterly-results-below-par/
No comments:
Post a Comment